Literature DB >> 23698129

First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm.

Gérard Amarenco1, Emmanuel Chartier-Kastler, Pierre Denys, Jacques Labat Jean, Marianne de Sèze, Catherine Lubetzski.   

Abstract

BACKGROUND: Urinary disorders that lead to urological complications are frequent in multiple sclerosis, resulting in diminished quality of life. Urinary management guidelines are scarce and targeted to neuro-urology specialists.
OBJECTIVE: This study aimed to construct and validate an algorithm dedicated to neurologists and general practitioners to facilitate first-line evaluation and treatment of urinary disorders associated with multiple sclerosis.
METHODS: 49 items concerning urological symptom evaluation and therapeutic strategies were derived from literature analysis and evaluated by an expert panel. The Delphi method established consensus between the experts and allowed development of the First-Line Urological Evaluation in Multiple Sclerosis (FLUE-MS) algorithm. Two questions from the Urinary Bothersome Questionnaire in Multiple Sclerosis were included and their validation to verify comprehensiveness and acceptability was also conducted.
RESULTS: Three rounds of expert review obtained consensus of all 49 items and allowed finalisation of the algorithm. Comprehension and acceptability of two Urinary Bothersome Questionnaire in Multiple Sclerosis questions were verified (mean comprehensiveness score: 1.99/2 [99.7% total comprehensiveness], mean acceptability score: 1.99/2 [99.1% complete acceptability]).
CONCLUSION: The FLUE-MS algorithm was designed for neurologists and general practitioners, enabling identification of 'red flags', timely patient referral to specialist neuro-urology units, and appropriate first-line therapy.

Entities:  

Keywords:  Algorithms; multiple sclerosis; overactive bladder; urinary incontinence; urinary incontinence – urge; urination disorders

Mesh:

Year:  2013        PMID: 23698129     DOI: 10.1177/1352458513489758

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

Review 1.  Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

Review 2.  [What is new in symptomatic MS treatment: Part 3-bladder dysfunction].

Authors:  T Henze; W Feneberg; P Flachenecker; D Seidel; H Albrecht; M Starck; S G Meuth
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

Review 3.  Treatment of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017-03-16       Impact factor: 1.862

Review 4.  Autonomic Dysregulation in Multiple Sclerosis.

Authors:  Alexandra Pintér; Domonkos Cseh; Adrienn Sárközi; Ben M Illigens; Timo Siepmann
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

5.  Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis.

Authors:  Pawel Bartnik; Aleksandra Wielgoś; Joanna Kacperczyk; Katarzyna Pisarz; Iwona Szymusik; Aleksandra Podlecka-Piętowska; Beata Zakrzewska-Pniewska; Miroslaw Wielgoś
Journal:  Brain Behav       Date:  2017-04-14       Impact factor: 2.708

6.  Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging Therapies.

Authors:  Riccardo Bientinesi; Carlo Gandi; PierFrancesco Bassi
Journal:  Int Neurourol J       Date:  2020-06-30       Impact factor: 2.835

7.  [Current aspects of neurogenic dysfunctions of the lower urinary tract in multiple sclerosis].

Authors:  Burkhard Domurath; Peter Flachenecker; Thomas Henze; Wolfgang Feneberg; Anna Brandt; Ines Kurze; Ruth Kirschner-Hermanns; Albert Kaufmann; Jörn Bremer; Manuela Vonthien; Kerstin Ratering; Christoph Schäfer; Will Nelson Vance; Paul Schmidt
Journal:  Nervenarzt       Date:  2021-01-05       Impact factor: 1.214

8.  Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis.

Authors:  Janina Beck; Anke Kirsten Jaekel; Federico Leopoldo Zeller; Michael Kowollik; Ines Kurze; Albert Kaufmann; Wolfgang Feneberg; Anna Brandt; Peter Flachenecker; Thomas Henze; Burkhard Domurath; Paul Schmidt; Will Nelson Vance; Franziska Goldschmidt; Ruth Klara Maria Kirschner-Hermanns; Stephanie C Knüpfer
Journal:  Diagnostics (Basel)       Date:  2022-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.